Lynn Pezzanite
Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Horse Diseases | 21 | 2026 | 80 | 9.770 |
Why?
| | Horses | 32 | 2026 | 229 | 4.710 |
Why?
| | Osteoarthritis | 7 | 2026 | 206 | 3.350 |
Why?
| | Synoviocytes | 3 | 2025 | 19 | 2.170 |
Why?
| | Laparoscopy | 4 | 2026 | 487 | 2.010 |
Why?
| | Chondrocytes | 4 | 2025 | 241 | 1.960 |
Why?
| | Synovial Membrane | 2 | 2026 | 130 | 1.600 |
Why?
| | Pedicle Screws | 2 | 2025 | 23 | 1.510 |
Why?
| | Spinal Fusion | 2 | 2025 | 265 | 1.210 |
Why?
| | Cervical Vertebrae | 3 | 2025 | 170 | 1.040 |
Why?
| | Animals | 41 | 2026 | 38107 | 1.020 |
Why?
| | Mesenchymal Stem Cell Transplantation | 4 | 2026 | 63 | 1.000 |
Why?
| | Anti-Bacterial Agents | 8 | 2025 | 1942 | 1.000 |
Why?
| | Hoof and Claw | 3 | 2023 | 8 | 0.960 |
Why?
| | Acrylic Resins | 1 | 2026 | 48 | 0.930 |
Why?
| | Cetacea | 1 | 2025 | 1 | 0.910 |
Why?
| | Synovial Fluid | 5 | 2026 | 69 | 0.890 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2026 | 196 | 0.840 |
Why?
| | Abdomen | 1 | 2025 | 142 | 0.830 |
Why?
| | Bupivacaine | 2 | 2023 | 43 | 0.780 |
Why?
| | Cellular Senescence | 1 | 2025 | 225 | 0.770 |
Why?
| | Arthritis, Infectious | 1 | 2024 | 77 | 0.750 |
Why?
| | Hydrogels | 2 | 2026 | 708 | 0.710 |
Why?
| | Lameness, Animal | 4 | 2023 | 27 | 0.700 |
Why?
| | Paranasal Sinus Diseases | 1 | 2021 | 15 | 0.680 |
Why?
| | Veterinarians | 1 | 2021 | 12 | 0.680 |
Why?
| | Endoscopy | 2 | 2021 | 316 | 0.660 |
Why?
| | Perioperative Period | 1 | 2021 | 69 | 0.650 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2021 | 81 | 0.640 |
Why?
| | Dogs | 2 | 2024 | 517 | 0.630 |
Why?
| | Immunomodulation | 1 | 2021 | 98 | 0.620 |
Why?
| | Amikacin | 1 | 2020 | 29 | 0.610 |
Why?
| | Toll-Like Receptors | 1 | 2021 | 193 | 0.610 |
Why?
| | Cartilage | 1 | 2021 | 198 | 0.590 |
Why?
| | Phagocytosis | 1 | 2021 | 298 | 0.580 |
Why?
| | Elective Surgical Procedures | 1 | 2021 | 216 | 0.580 |
Why?
| | Postoperative Complications | 3 | 2026 | 3034 | 0.570 |
Why?
| | Injections, Intra-Articular | 5 | 2026 | 64 | 0.540 |
Why?
| | Hindlimb | 1 | 2018 | 128 | 0.540 |
Why?
| | Cell Survival | 1 | 2021 | 1105 | 0.520 |
Why?
| | Gene Expression Regulation | 2 | 2025 | 2599 | 0.490 |
Why?
| | Anastomosis, Surgical | 1 | 2017 | 164 | 0.490 |
Why?
| | Colectomy | 1 | 2017 | 119 | 0.490 |
Why?
| | Staphylococcus aureus | 1 | 2021 | 459 | 0.490 |
Why?
| | Cartilage, Articular | 1 | 2020 | 366 | 0.470 |
Why?
| | T-Lymphocytes | 1 | 2024 | 2012 | 0.440 |
Why?
| | Aging | 1 | 2025 | 1996 | 0.430 |
Why?
| | Transplantation, Homologous | 1 | 2015 | 416 | 0.400 |
Why?
| | Antibody Formation | 1 | 2015 | 290 | 0.400 |
Why?
| | Bone Marrow Cells | 1 | 2015 | 328 | 0.400 |
Why?
| | Anesthetics, Local | 2 | 2023 | 106 | 0.360 |
Why?
| | Cadaver | 2 | 2025 | 304 | 0.350 |
Why?
| | Movement Disorders | 2 | 2023 | 68 | 0.320 |
Why?
| | Biomechanical Phenomena | 4 | 2026 | 874 | 0.290 |
Why?
| | Female | 13 | 2026 | 79499 | 0.270 |
Why?
| | Sepsis | 2 | 2026 | 669 | 0.250 |
Why?
| | Male | 9 | 2026 | 73396 | 0.240 |
Why?
| | Fuzzy Logic | 1 | 2026 | 13 | 0.240 |
Why?
| | Wound Healing | 2 | 2025 | 354 | 0.230 |
Why?
| | Synovitis | 1 | 2026 | 35 | 0.230 |
Why?
| | Receptors, Pattern Recognition | 1 | 2025 | 14 | 0.230 |
Why?
| | Rotator Cuff | 1 | 2025 | 62 | 0.220 |
Why?
| | History, 21st Century | 1 | 2026 | 224 | 0.220 |
Why?
| | Rotator Cuff Injuries | 1 | 2025 | 79 | 0.220 |
Why?
| | Vancomycin | 1 | 2025 | 96 | 0.210 |
Why?
| | Wound Infection | 1 | 2025 | 60 | 0.210 |
Why?
| | History, 20th Century | 1 | 2026 | 330 | 0.210 |
Why?
| | Veterinary Medicine | 1 | 2024 | 12 | 0.210 |
Why?
| | Antifibrinolytic Agents | 1 | 2025 | 68 | 0.210 |
Why?
| | Tranexamic Acid | 1 | 2025 | 63 | 0.210 |
Why?
| | Retrospective Studies | 7 | 2022 | 17438 | 0.210 |
Why?
| | Regenerative Medicine | 1 | 2024 | 48 | 0.210 |
Why?
| | Joints | 1 | 2025 | 107 | 0.200 |
Why?
| | Tissue Scaffolds | 1 | 2026 | 223 | 0.200 |
Why?
| | Stem Cell Transplantation | 1 | 2024 | 190 | 0.190 |
Why?
| | Adrenalectomy | 1 | 2023 | 68 | 0.190 |
Why?
| | Conjunctival Neoplasms | 1 | 2022 | 9 | 0.190 |
Why?
| | Leukocytes, Mononuclear | 1 | 2025 | 585 | 0.190 |
Why?
| | Eye Neoplasms | 1 | 2022 | 31 | 0.180 |
Why?
| | Forelimb | 4 | 2023 | 42 | 0.180 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2023 | 253 | 0.180 |
Why?
| | Range of Motion, Articular | 1 | 2025 | 446 | 0.180 |
Why?
| | Pheochromocytoma | 1 | 2023 | 67 | 0.180 |
Why?
| | Ovariectomy | 1 | 2023 | 164 | 0.180 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2023 | 99 | 0.170 |
Why?
| | Periodicals as Topic | 1 | 2024 | 214 | 0.170 |
Why?
| | Tissue Engineering | 1 | 2026 | 442 | 0.170 |
Why?
| | Biocompatible Materials | 1 | 2025 | 432 | 0.170 |
Why?
| | Cathelicidins | 1 | 2021 | 40 | 0.170 |
Why?
| | Analgesia | 1 | 2022 | 106 | 0.160 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2021 | 77 | 0.160 |
Why?
| | Pain | 2 | 2023 | 790 | 0.150 |
Why?
| | Blood Platelets | 1 | 2023 | 382 | 0.150 |
Why?
| | Staphylococcal Infections | 1 | 2024 | 397 | 0.150 |
Why?
| | Spinal Cord Compression | 1 | 2019 | 24 | 0.140 |
Why?
| | Osteoarthritis, Knee | 1 | 2022 | 291 | 0.140 |
Why?
| | Radiography | 1 | 2021 | 861 | 0.140 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 349 | 0.140 |
Why?
| | Biofilms | 1 | 2021 | 288 | 0.140 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2022 | 628 | 0.130 |
Why?
| | Microbiota | 1 | 2025 | 725 | 0.130 |
Why?
| | Transcriptome | 1 | 2024 | 1068 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2024 | 1792 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 769 | 0.120 |
Why?
| | Glycerol | 1 | 2015 | 90 | 0.110 |
Why?
| | Neutrophils | 1 | 2021 | 1133 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 970 | 0.110 |
Why?
| | Sex Factors | 1 | 2021 | 2107 | 0.110 |
Why?
| | Major Histocompatibility Complex | 1 | 2015 | 234 | 0.100 |
Why?
| | Treatment Outcome | 2 | 2021 | 11821 | 0.100 |
Why?
| | Genes, MHC Class II | 1 | 2014 | 77 | 0.100 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4580 | 0.100 |
Why?
| | Prospective Studies | 2 | 2023 | 8123 | 0.100 |
Why?
| | Cytokines | 1 | 2021 | 2081 | 0.090 |
Why?
| | Antibodies | 1 | 2015 | 400 | 0.090 |
Why?
| | Apoptosis | 1 | 2020 | 2439 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2219 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2018 | 3647 | 0.080 |
Why?
| | Gait | 2 | 2023 | 322 | 0.080 |
Why?
| | Inflammation | 2 | 2022 | 2919 | 0.070 |
Why?
| | Colorado | 1 | 2017 | 4595 | 0.060 |
Why?
| | Humans | 8 | 2026 | 146342 | 0.060 |
Why?
| | Liver | 1 | 2015 | 1864 | 0.060 |
Why?
| | Cohort Studies | 1 | 2017 | 6077 | 0.060 |
Why?
| | Tenocytes | 1 | 2026 | 5 | 0.060 |
Why?
| | Carboxymethylcellulose Sodium | 1 | 2025 | 5 | 0.060 |
Why?
| | Biopolymers | 1 | 2025 | 31 | 0.060 |
Why?
| | Osteoblasts | 1 | 2026 | 145 | 0.060 |
Why?
| | Intraoperative Complications | 1 | 2026 | 157 | 0.050 |
Why?
| | Tendons | 1 | 2026 | 136 | 0.050 |
Why?
| | Pets | 1 | 2024 | 28 | 0.050 |
Why?
| | Microbial Sensitivity Tests | 1 | 2025 | 367 | 0.050 |
Why?
| | Particle Size | 1 | 2025 | 386 | 0.050 |
Why?
| | Materials Testing | 1 | 2025 | 345 | 0.050 |
Why?
| | Cats | 1 | 2024 | 226 | 0.050 |
Why?
| | Fetal Blood | 1 | 2026 | 325 | 0.050 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2024 | 82 | 0.050 |
Why?
| | Stress, Mechanical | 1 | 2026 | 497 | 0.050 |
Why?
| | Bone and Bones | 1 | 2026 | 319 | 0.050 |
Why?
| | Sheep | 1 | 2025 | 870 | 0.050 |
Why?
| | Guinea Pigs | 1 | 2022 | 159 | 0.050 |
Why?
| | Injections, Intravenous | 1 | 2022 | 197 | 0.040 |
Why?
| | Cefazolin | 1 | 2022 | 22 | 0.040 |
Why?
| | Arthrodesis | 1 | 2022 | 38 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2023 | 327 | 0.040 |
Why?
| | Gentamicins | 1 | 2022 | 50 | 0.040 |
Why?
| | Models, Animal | 1 | 2023 | 387 | 0.040 |
Why?
| | Computer Simulation | 1 | 2026 | 1014 | 0.040 |
Why?
| | Interferon-alpha | 1 | 2022 | 201 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2022 | 426 | 0.040 |
Why?
| | Knee Joint | 1 | 2022 | 453 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2026 | 1982 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1888 | 0.030 |
Why?
| | Immunotherapy | 1 | 2022 | 671 | 0.030 |
Why?
| | Rats | 1 | 2025 | 5586 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 738 | 0.030 |
Why?
| | Cottonseed Oil | 1 | 2015 | 1 | 0.030 |
Why?
| | Medicago sativa | 1 | 2015 | 3 | 0.030 |
Why?
| | Pyruvate Carboxylase | 1 | 2015 | 3 | 0.030 |
Why?
| | Rumen | 1 | 2015 | 9 | 0.030 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2015 | 14 | 0.030 |
Why?
| | Glucose-6-Phosphatase | 1 | 2015 | 32 | 0.030 |
Why?
| | Animal Feed | 1 | 2015 | 50 | 0.030 |
Why?
| | Zea mays | 1 | 2015 | 45 | 0.030 |
Why?
| | Gluconeogenesis | 1 | 2015 | 81 | 0.030 |
Why?
| | Micronutrients | 1 | 2015 | 102 | 0.030 |
Why?
| | Cattle | 1 | 2015 | 940 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2014 | 324 | 0.020 |
Why?
| | Leukocytes | 1 | 2014 | 301 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2014 | 781 | 0.020 |
Why?
| | Diet | 1 | 2015 | 1273 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2791 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4118 | 0.010 |
Why?
|
|
Pezzanite's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|